Skip to main content

Table 4 Liver function test, coagulation tests, and additional renal tests

From: A challenging case of COVID-19: a COVID-19 positive adolescent presented with severe diabetic ketoacidosis, resistant hypertension

 

During admission

Ref

AST U/L

18

7–55

ALT U/L

13

8–48

ALK-Ph U/L

636

40–129

Bili T. mg/dL

1.1

0.1–1.2

Bili D. mg/dl

0.5

<0.3

CPK U/L

81

39–308

LDH U/L

711

140–280

Alb g/dL

3.15

3.4–5.4

Amylase U/L

34

23–85

Lipase U/L

36

0–160

PT sec

13

10–13

PTT sec

27

25–36

INR

1

0.9–1.15

CL mmol/L

97.9

95–110

Anti-DNA IU/mL

1.2

< 30.0

C3 g/L

152

0.9–1.8

C4 g/L

57

 

CH50 mg/dl

89.4

low:0–100

nl:101–300

hi > 301

ANA u/ml

0.7

neg. < 0.8

equ:0.8–1.2

pos. < 1.2

ANCA

0.6

neg .< 12

equ:12–18

pos. < 18

P ANCA

0.1

Urine24h,cr mg/24 h

575

800–2000

Urine24h,pro.mg/24 h

497

Urine24h,vol. ml

1150

600–2500

Urine24h,k meq/24 h

49.5

30–120